Beijing Sungen Biomedical Technology Co., Ltd

This early-stage study tested a new drug called SGC001 in 38 Chinese patients who had just suffered a severe type of heart attack (anterior STEMI). The main goal was to check if the drug is safe and to find the right dose for future studies. Researchers also looked for early sign…

This was an early safety study of an experimental drug called SGC001, which is being developed for heart attacks. The study tested single, increasing doses in 49 healthy adults to see how safe it is and how the body processes it. The main goal was to check for side effects and un…